Alex Zhavoronkov - CEO Insilico Medicine

12 snips

Jun 10, 2023

Alex Zhavoronkov, CEO of Insilico Medicine, discusses the progress and capabilities of Insilico Medicine, an AI-powered drug discovery company. They emphasize the need for validation and optimizing success probability in using AI tools in drug discovery. They also explore the evolution of Insilico Medicine into a software company and the importance of partnering with pharmaceutical companies. Furthermore, they discuss how In Silico aligns with the theme of science and innovation and their commitment to maximizing life through advancements in AI and future technologies.

Ask episode

Chapters

Transcript

Episode notes

Introduction

00:00 • 2min

AI-Powered Drug Discovery and Clinical Trials

01:35 • 8min

Evolution to a Software Company and Partnering with Pharma Companies

09:33 • 6min

Aligning in silico with the theme of standing up for science and innovation

16:01 • 3min

Maximizing Life, AI, and Future Technologies

18:36 • 6min